A partir d'une revue systématique de la littérature publiée jusqu'en juillet 2023 (16 études, 893 patients), cette méta-analyse évalue l'intérêt des thérapies par la danse et le mouvement pour améliorer la qualité de vie et réduire les symptômes (anxiété, dépression, troubles du sommeil, etc.) des patients atteints d'un cancer ou recevant des soins palliatifs

Effectiveness of dance movement therapy and dance movement interventions on cancer patients’ health-related outcomes: a systematic review and meta-analysis

Abu-Odah, Hammoda ; Wang, Mian ; Su, Jing Jing ; Collard-Stokes, Gemma ; Sheffield, David ; Molassiotis, Alex

Objectives: This review examined the effectiveness of using dance movement therapy (DMT) and dance movement interventions (DMIs) with cancer and palliative care patients. Methods: A systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Six databases were searched from inception to July 9, 2022, without limits on year or age. Searching was updated on July 10, 2023. The risk of bias was assessed by the [...]

Cette étude présente les recommandations de l'"American Society of Clinical Oncology" concernant l'utilisation du cannnabis thérapeutique et des cannabinoïdes chez les patients atteints d'un cancer

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline

Ilana M. Braun ; Kari Bohlke ; Donald I. Abrams ; Holly Anderson ; Lynda G. Balneaves ; Gil Bar-Sela ; Daniel W. Bowles ; Peter R. Chai ; Anuja Damani ; Arjun Gupta ; Sigrun Hallmeyer ; Ishwaria M. Subbiah ; Chris Twelves ; Mark S. Wallace ; Eric J. Roeland

PURPOSE: To guide clinicians, adults with cancer, caregivers, researchers, and oncology institutions on the medical use of cannabis and cannabinoids, including synthetic cannabinoids and herbal cannabis derivatives; single, purified cannabinoids; combinations of cannabis ingredients; and full-spectrum cannabis. METHODS: A systematic literature review identified systematic reviews, randomized controlled trials (RCTs), and cohort studies on the efficacy and safety of cannabis and cannabinoids [...]

Cette étude présente la mise à jour des recommandations d'un panel d'experts multidisciplinaires concernant l'utilisation de l'acupuncture dans la prise en charge des patients atteints d'un cancer

Acupuncture in cancer care: recommendations for safe practice (peer-reviewed expert opinion)

de Valois, Beverley ; Young, Teresa ; Zollman, Catherine ; Appleyard, Ian ; Ben-Arye, Eran ; Cummings, Mike ; Green, Ruth ; Hoffman, Caroline ; Lacey, Judith ; Moir, Felicity ; Peckham, Rachel ; Stringer, Jacqui ; Veleber, Susan ; Weitzman, Matthew ; Wode, Kathrin

Background: Up-to-date recommendations for the safe practice of acupuncture in integrative oncology are overdue with new cancer treatments and an increase in survivors with late effects of disease; 17 years have elapsed since Filshie and Hester’s 2006 guidelines. During 2022/2023 an expert panel assembled to produce updated recommendations aiming to facilitate safe and appropriate care by acupuncturists working with people with cancer. Methods: A core development team comprising three [...]

Cet article fait le point sur le rôle du cannabis thérapeutique dans la prise en charge de la douleur liée au cancer, notamment pour réduire les disparités ethniques

Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management

Gibson, Laurel P ; Ferrer, Rebecca A ; Meghani, Salimah H ; Acevedo, Amanda M

Cancer-related pain affects a significant proportion of all cancer patients yet remains inadequately managed, particularly among cancer patients from racialized backgrounds. In recent years, there has been increased research and clinical interest in the use of medical cannabis for cancer pain management, including its potential to ameliorate racialized disparities in cancer pain control. Although medical cannabis is not currently an FDA-approved treatment option for cancer-related pain, many [...]

Menée aux Etats-Unis à partir de données 2015-2021 portant sur 89 569 vétérans dont 9 073 patients atteints d'un cancer, cette étude analyse l'utilisation d'opioïdes pour soulager la douleur liée au cancer

Opioid use in cancer patients compared with non-cancer pain patients in a veterans population

Mudumbai, Seshadri C ; He, Han ; Chen, Ji-Qing ; Kapoor, Aditi ; Regala, Samantha ; Mariano, Edward R ; Stafford, Randall S ; Abnet, Christian C ; Pfeiffer, Ruth M ; Freedman, Neal D ; Etemadi, Arash

Background: Opioid safety initiatives may secondarily impact opioid prescribing and pain outcomes for cancer care. Methods: We reviewed electronic health record data at a tertiary Veterans Affairs system (VA Palo Alto) for all patients from 2015-2021. We collected outpatient Schedule II opioid prescriptions data and calculated morphine milligram equivalents (MMEs) using CDC conversion formulas. To determine the clinical impact of changes in opioid prescription, we used the highest level of pain [...]

A partir d'une revue de la littérature publiée jusqu'en août 2022 (51 articles), cette étude analyse l'association entre l'image corporelle et la qualité de vie des patientes atteintes d'un cancer du sein traité par chirurgie

What is the relationship between body image and the quality of life of women who underwent surgery for breast cancer? A scoping review

Battistello, Camila Zanella ; da Silva, Nathália Weschenfelder ; Remor, Eduardo

Purpose: This review aimed to identify, characterize, map, and summarize existing knowledge about the relationship of perceived body image with the quality of life (QoL) of women who have undergone surgical treatment for breast cancer. Methods: A scoping review was conducted following the PRISMA-ScR guidelines. PubMed, PsycINFO and Scopus databases were searched, and articles published until August 2022 were included. Results: The search resulted in 796 records, and 51 articles were included [...]

Mené sur 503 patientes atteintes d'un cancer du sein de stade précoce, cet essai randomisé de phase III compare l'intérêt, du point de vue de la qualité de vie, d'un suivi individualisé mené par des infirmières et de visites de contrôle régulières par le médecin, après la fin des traitements anticancéreux

Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial

Lena Saltbæk ; Pernille E. Bidstrup ; Randi V. Karlsen ; Beverley L. Høeg ; Trine A. Horsboel ; Federica Belmonte ; Elisabeth A.W. Andersen ; Vibeke Zoffmann ; Anne S. Friberg ; Mads N. Svendsen ; Helle G. Christensen ; Vesna Glavicic ; Dorte L. Nielsen ; Susanne O. Dalton ; Christoffer Johansen

PURPOSE: Follow-up after breast cancer with regular visits has failed to detect recurrences, be cost-effective, and address patient needs. METHODS: MyHealth is a phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT02949167). Patients, who recently completed primary treatment for stage I-II breast cancer, were randomly assigned in variable block sizes and stratified by age and human epidermal growth factor receptor 2 status to intervention or control follow-up. The nurse-led [...]

Menée à partir de données du projet "Global Burden of Disease Study 2019", cette étude évalue la part des maladies non transmissibles (dont le cancer du poumon, le cancer de l'ovaire et le mésothéliome) attribuable à une exposition professionnelle à l'amiante

Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990–2019 and prediction to 2035: worsening or improving?

Miao, Xinlu ; Yao, Teng ; Dong, Chenxian ; Chen, Zuhai ; Wei, Wanting ; Shi, Zhengyang ; Xu, Tongtong ; Shao, Jianjiang ; Niu, Qiang ; Rui, Dongsheng ; Hu, Yunhua ; Yan, Yizhong

Understanding the burden associated with occupational asbestos exposure on a global and regional scale is necessary to implement coordinated prevention and control strategies. By the GBD Study 2019, we conducted a comprehensive assessment of the non-communicable diseases burden attributable to occupational asbestos exposure. In 2019, 239,330 deaths and 4,189,000 disability-adjusted life years (DALYs) worldwide due to occupational asbestos exposure occurred. 1990–2019, deaths and DALYs [...]

Menée à partir de données des registres des cancers portant au total sur 12 061 enfants ou jeunes adolescents atteints d'un cancer diagnostiqué sur la période 2004-2015, cette étude compare l'incidence des cancers, la survie et la mortalité aux Pays-Bas et en Belgique

Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population-based study

Peirelinck, Hanne ; Schulpen, Maya ; Hoogendijk, Raoull ; Van Damme, An ; Pieters, Rob ; Henau, Kris ; Van Damme, Nancy ; Karim-Kos, Henrike E.

International comparisons of cancer surveillance measures may provide insight into inequalities in registration practices, etiological factors, and treatment strategies. This study aimed to compare incidence, survival, and mortality of cancer in children and young adolescents between Belgium and the Netherlands. All children (0–14 years) and young adolescents (15–17 years) diagnosed with cancer between 2004 and 2015 were selected from the population-based cancer registries of Belgium (N = 4739) [...]

Menée aux Etats-Unis à partir de données portant sur 644 adultes ayant survécu à une leucémie pédiatrique (âge médian : 24,7 ans), cette étude de cohorte analyse l'association entre la survenue d'une sepsis sévère pendant les traitements anticancéreux et le risque de maladie chronique à l'âge adulte

Severe Sepsis During Treatment for Childhood Leukemia and Sequelae Among Adult Survivors

Goggin, Kathryn P. ; Lu, Lu ; Lee, Danielle E. ; Howell, Carrie R. ; Srivastava, Deokumar ; Brinkman, Tara M. ; Armstrong, Gregory T. ; Bhakta, Nickhill ; Robison, Leslie L. ; Ehrhardt, Mathew J. ; Hudson, Melissa M. ; Krull, Kevin R. ; Pui, Ching-Hon ; Rubnitz, Jeffrey ; Ness, Kirsten K. ; Wolf, Joshua

Importance : Children undergoing treatment for leukemia are at increased risk of severe sepsis, a dysregulated immune response to infection leading to acute organ dysfunction. As cancer survivors, they face a high burden of long-term adverse effects. The association between sepsis during anticancer therapy and long-term organ dysfunction in adult survivors of childhood cancer has not been examined. Objective : To determine whether severe sepsis during therapy for leukemia in childhood is [...]

Menée à partir de données du registre californien des cancers portant sur 207 429 patients décédés d'un cancer du poumon sur la période 2005-2018 (âge médian : 74 ans), cette étude analyse l'intensité des soins reçus en fin de vie en fonction de l'origine ethnique

Racial and Ethnic Disparities in Intensity of Care at the End of Life for Patients With Lung Cancer: A 13-Year Population-Based Study

Gladys M. Rodriguez ; Rita Popat ; Lisa G. Rosas ; Manali I. Patel

PURPOSE: Lung cancer is the leading cause of cancer death in the United States. Disparities in lung cancer mortality among racial and ethnic minorities are well documented. Less is known as to whether racial and ethnic minority patients with lung cancer experience higher rates of intensity of care at the end of life (EOL) compared with non-Hispanic White (NHW) patients. METHODS: We conducted a population-based analysis of patients 18 years and older with a lung cancer diagnosis who died between [...]

Menée à partir de données portant sur 265 patients atteints d'un cancer du poumon non à petites cellules de stade localement avancé, cette étude analyse l'impact, sur la survie, du statut tabagique avant la chimioradiothérapie

The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer

Wallace, Neil D. ; Alexander, Marliese ; Xie, Jing ; Ball, David ; Hegi-Johnson, Fiona ; Plumridge, Nikki ; Siva, Shankar ; Shaw, Mark ; Harden, Susan ; John, Tom ; Solomon, Ben ; Officer, Ann ; MacManus, Michael

Introduction: Smoking is a risk factor for the development of lung cancer and reduces life expectancy within the general population. Retrospective studies suggest that non-smokers have better outcomes after treatment for lung cancer. We used a prospective database to investigate relationships between pre-treatment smoking status and survival for a cohort of patients with stage III non-small-cell lung cancer (NSCLC) treated with curative-intent concurrent chemoradiotherapy (CRT). Methods: All [...]

Menée à partir de données portant sur 1 199 patients atteints d'un cancer de la prostate sensible à la castration, de stade métastatique, à haut risque de récidive et inclus dans un essai de phase III évaluant l'efficacité d'une thérapie anti-androgénique avec ou sans acétate d'abiratérone combiné à la prednisone, cette étude de cohorte analyse l'association entre une utilisation de bisphosphonates ou de dénosumab et la survenue d'événéments indésirables liés au squelette ainsi que la survie globale

Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate

Fukuokaya, Wataru ; Mori, Keiichiro ; Urabe, Fumihiko ; Igarashi, Taro ; Yanagisawa, Takafumi ; Tsuzuki, Shunsuke ; Honda, Mariko ; Miki, Kenta ; Kimura, Takahiro

Importance : The association between the use of bone-modifying agents (BMAs) and the outcomes among patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with abiraterone acetate plus prednisone (AAP) remains unclear. Objective : To investigate the association between BMA use and the outcomes of patients with mCSPC receiving AAP. Design, Setting, and Participants : In this cohort study, a post hoc analysis of individual participant data from the LATITUDE trial was [...]

Menée à partir de données portant sur 4 756 patients atteints d'un cancer de la prostate non métastatique (durée médiane de suivi : 11 ans), cette étude analyse l'association entre une supplémentation en multivitamines après le diagnostic et la survie (2 609 décès)

Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer

Zhang, Yiwen ; Stopsack, Konrad H. ; Wu, Kana ; Song, Mingyang ; Mucci, Lorelei A. ; Giovannucci, Edward

Background: Multivitamin use is common among cancer patients. Whether post-diagnostic multivitamin supplementation is beneficial for prostate cancer survival is largely unknown, and some evidence even suggests potential harm. Methods: We prospectively assessed post-diagnostic multivitamin use in relation to prostate cancer survival among 4756 men with nonmetastatic prostate cancer at diagnosis in the Health Professionals Follow-up Study (1986–2016). Cox regression models were used to evaluate [...]

Menée à l'aide d'une méthode de randomisation mendélienne et de données de deux cohortes prospectives, cette étude analyse l'association entre le niveau sérique de 25-hydroxyvitamine D et la survie chez des patients atteints d'un cancer colorectal

Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

Zhang, Xiaomeng ; He, Yazhou ; Li, Xue ; Shraim, Rasha ; Xu, Wei ; Wang, Lijuan ; Farrington, Susan M. ; Campbell, Harry ; Timofeeva, Maria ; Zgaga, Lina ; Vaughan-Shaw, Peter ; Theodoratou, Evropi ; Dunlop, Malcolm G.

Background: To investigate the association between circulating 25-hydroxyvitamin D (25-OHD) and colorectal cancer (CRC) survival outcomes. Methods: We conducted analyses among the Study of Colorectal Cancer in Scotland (SOCCS) and the UK Biobank (UKBB). Both cancer-specific survival (CSS) and overall survival (OS) outcomes were examined. The 25-OHD levels were categorised into three groups, and multi-variable Cox-proportional hazard models were applied to estimate hazard ratios (HRs). We [...]

Menée à partir de données portant sur 137 enfants et jeunes adultes atteints d'un sarcome des tissus mous (hors rhabdomyosarcome) réfractaire ou récidivant et inclus dans 13 essais de phase II, cette étude rétrospective estime la survie sans événement en fonction des traitements reçus, de l'origine ethnique, du sexe et de l'histologie de la tumeur

Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children’s Oncology Group

Oberoi, Sapna ; Qumseya, Amira ; Xue, Wei ; Venkatramani, Rajkumar ; Weiss, Aaron R.

Background : The aim of this study was to estimate the event-free survival (EFS) of children and young adults with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) treated in nonrandomized phase 2 studies conducted by the Children’s Oncology Group (COG) and predecessor groups to establish a benchmark EFS for future phase 2 NRSTS trials evaluating the activity of novel agents. Methods: A retrospective analysis of patients with recurrent or refractory NRSTS prospectively [...]

Menée à partir de données des registres américains des cancers et du registre des vétérans portant sur 73 763 patients atteints d'un cancer de la prostate métastatique hormono-sensible, cette étude analyse l'évolution de la survie globale entre 2000 et 2019

Survival in Patients With De Novo Metastatic Prostate Cancer

Schoen, Martin W. ; Montgomery, R. Bruce ; Owens, Lukas ; Khan, Saira ; Sanfilippo, Kristen M. ; Etzioni, Ruth B.

Overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) has improved in clinical trials over the last 20 years.1,2 It is unclear whether new treatments have translated to improvements in survival rates in clinical practice. We sought to quantify trends in OS among patients with newly diagnosed de novo (synchronous) mHSPC in 2 national registries in the United States: the Surveillance, Epidemiology, and End Results 17 (SEER) registry database and the Veterans Health [...]

Menée par projection et à partir des données 2010-2022 de l'OMS et de l'UNICEF portant sur la vaccination contre le papillomavirus humain (HPV), cette étude analyse l'effet de l'équité vaccinale sur la mortalité par cancer du col de l'utérus dans 84 pays

Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study

Abbas, Kaja ; Yoo, Katelyn Jison ; Prem, Kiesha ; Jit, Mark

Background: While human papillomavirus (HPV) vaccines have been available since 2006, the coverage has varied among countries. Our aim is to analyse the equity impact of HPV vaccination on the lifetime projections of cervical cancer burden among vaccinated cohorts of 2010–22 in 84 countries. Methods: We used WHO and UNICEF estimates of national immunisation coverage for HPV vaccination in 84 countries during 2010–22. We used PRIME (Papillomavirus Rapid Interface for Modelling and Economics) to [...]

Menée à partir de données portant sur 181 jeunes adultes ayant survécu à un cancer (âge : 18-39 ans), cette étude analyse l'association entre l'environnement social (cohésion, valeurs partagées, infrastructures et magasins, transports, espaces verts, activités de loisirs, etc.) et le sentiment de solitude

The association between neighborhood social and built environment on loneliness among young adults with cancer

Darabos, Katie ; Manne, Sharon L. ; Devine, Katie A.

Purpose: Young adults with cancer (YAs, aged 18–39) are at increased risk of experiencing loneliness due to their unique challenges of coping with a cancer diagnosis and treatment during young adulthood. Understanding factors that impact loneliness is critical to improving survivorship outcomes for this vulnerable YA population. Neighborhoods are key determinants of health. However, little is known about how such neighborhood characteristics are associated with loneliness among YA survivors. [...]

Menée à partir des données des registres américains des cancers et de la base Medicare portant sur 6 120 patients atteints d'un cancer du poumon non à petites cellules de stade précoce, cette étude analyse les disparités dans l'accès à des réunions de consultations pluridisciplinaires et dans les traitements reçus

Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis

Liu, You-Chi ; Schmidt, Rachel O. ; Kapadia, Nirav S. ; Phillips, Joseph D. ; Moen, Erika L.

Purpose: Disparities in access to multidisciplinary cancer consultations (MDCc) persist, and the role of physician relationships remains understudied. This study examined the extent to which multilevel factors, including patient characteristics and patient-sharing network measures reflecting the structure of physician relationships, are associated with MDCc and receipt of stereotactic body radiation therapy (SBRT) versus surgery among early-stage non-small cell lung cancer (NSCLC) patients. [...]